[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
Einsele
H
H
Medizinische Klinik II, Universität Tübingen. hneinsel@med.uni-tuebingen.de
Bertz
H
H
Beyer
J
J
Kiehl
M G
MG
Runde
V
V
Kolb
H J
HJ
Holler
E
E
Beck
R
R
Schwerdfeger
R
R
Schumacher
U
U
Hebart
H
H
Martin
H
H
Kienast
J
J
Ullmann
A J
AJ
Maschmeyer
G
G
Krüger
W
W
Link
H
H
Schmidt
C A
CA
Oettle
H
H
Klingebiel
T
T
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D005334:Fever / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D009503:Neutropenia / Q000150:complications; D009504:Neutrophils; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D014123:Toxoplasmosis / Q000175:diagnosis / Q000628:therapy; D014184:Transplantation, Homologous; D014777:Virus Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000998:Antiviral Agents